Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: A possible cause for variations in the prevalence of filamentous fungi

Medical Mycology

Volumn 48, Issue O1, 2010, Pages

  Borman, Andrew M ^a   Palmer, Michael D ^a   Delhaes, Laurence ^b   Carrère, Jacqueline ^c   Favennec, Loïc ^d   Ranque, Stéphane ^e   Gangneux, Jean Pierre ^f   Horré, Regine ^g   Bouchara, Jean Philippe ^h  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIV LILLE   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e TIMONE HOSPITAL   (France)

^f RENNES UNIVERSITY HOSPITAL   (France)

^g Federal Institute for Drugs and Medical Devices   (Germany)

^h UNIVERSITÉ D'ANGERS   (France)

Author keywords

culture methods; cystic fibrosis; filamentous fungi; respiratory samples; yeasts

Indexed keywords

ARTICLE; BIOTA; CYSTIC FIBROSIS; FUNGAL CELL CULTURE; FUNGAL DETECTION; FUNGAL VIRULENCE; FUNGUS; FUNGUS ISOLATION; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; NONHUMAN; PREVALENCE; SAMPLE; SPUTUM; STANDARDIZATION;

ASPERGILLUS FUMIGATUS; EXOPHIALA DERMATITIDIS; FUNGI; PENICILLIUM; PSEUDALLESCHERIA;

EID: 78649943740     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.511287     Document Type: Article

References (36)

1. Koch C, Høiby N. Diagnosis and treatment of cysticf brosis. Respiration 2000; 67: 239-247.
2. Lommatzsch ST, Aris R. Genetics of cysticf brosis. Semin Respir Crit Care Med 2009; 30: 531-538.
3. Sibley CD, Rabin H, Surette MG. Cysticf brosis: a polymicrobial infectious disease. Future Microbiol 2006; 1: 53-61.
4. Goss CH, Burns JL. Exacerbations in cysticf brosis. 1: Epidemiology and pathogenesis. Thorax 2007; 62: 360-367.
5. Gilligan PH. Microbiology of airway disease in patients with cysticf brosis. Clin Microbiol Rev 1991; 4: 35-51.
6. Pihet M, Carrère J, Cimon B, et al. Occurrence and relevance off lamentous fungi in respiratory secretions of patients with cysticf brosis. Med Mycol 2009; 47: 387-397.
7. Cimon B, Carrère J, Chazalette J P, et al. Fungal colonisation and immune response to fungi in cysticf brosis. J Mycol Méd 1995; 5: 211-216.
8. Bakare N, Rickerts V, Bargon J, Just-Nübling, G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cysticf brosis. Mycoses 2003; 46: 19-23.
9. Elphick H, Southern K. Antifungal therapies for allergic broncho-pulmonary aspergillosis in people with cysticf brosis. Cochrane Database Syst Rev 2000; 4: CD002204.
10. De Almeida MB, Bussamra MH, Rodrigues JC. Allergic bronchopul-monary apsergillosis in paediatric cysticf brosis patients. Paediatr Repir Rev 2006; 7: 67-72.
11. Laufer P, Fink JN, Bruns WT, et al. Allergic bronchopulmonary asper-gillosis in cysticf brosis. J Allergy Clin Immunol 1984; 73: 44-48.
12. Cimon B, Carrère J, Vinatier JF, et al. Clinical signif cance of Scedosporium apiospermum in patients with cysticf brosis. Eur J Clin Microbiol Infect 2000; 19: 53-56.
13. Cimon B, Zouhair R, Symoensf et al. Aspergillus terreus in a cysticf brosis clinic: environmental distribution and patient colonisation pattern. J Hosp Infect 2003; 53: 81-82.
14. Horré R, Marklein G, Siekmeier R, Nidermajer S, Reiffert SM. Selective isolation of Pseudallescheria and Scedosporium species from respiratory tract specimens of cysticf brosis patients. Respiration 2009; 77: 320-324.
15. Barton RC, Borman AM, Johnson EM, et al. Isolation of the fungus Geosmithiaargillacea in the sputum of people with cysticf brosis. J Clin Microbiol 2010; 48: 2615-2617.
16. Horré R, Schaal KP, Siekmeier R, et al. Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cysticf brosis. Respiration. 2004, 71, 360-366.
17. Symoens F, Knoop C, Schrooyen M, et al. Disseminated Scedosporium apiospermum infection in a cysticf brosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25: 603-607.
18. Iversen M, Burton CM, Vand S, et al. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007; 26: 879-886.
19. Muthig M, Hebestreit A, Ziegler U, Seidler M, Muller F-MC. Persistence of Candida species in the respiratory tract of cysticf brosis patients. Med Mycol 2010; 48: 56-63.
20. Nagano Y, Elborn JS, Millar BC, et al. Comparison of techniques to examine the diversity of fungi in adult patients with cysticf brosis. Med Mycol 2010; 48: 166-176.
21. Roig E, Malo JL, Montplaisir S, Anti- Candida albicans IgE and IgG subclasses in sera of patients with allergic bronchopulmonary aspergillosis (ABPA). Allergy 1997; 52: 394-403.
22. Máiz L, Cuevas M, Quirce S et al. Serologic IgE immune responses against Aspergillus fumigatus and Candida albicans in patients with cysticf brosis. Chest 2002; 121: 782-788.
23. Haase G, Shopnik H, Kusenbach G. Exophiala dermatitidis infection in cysticf brosis. Lancet 1990; 336: 188-189.
24. Matos T, De Hoog GS, De Boer AG, De Crom I, Haase G. High prevalence of the neurotropic Exophiala dermatitidis and related olig-otrophic black yeasts in sauna facilities. Mycoses 2002; 45: 373-377.
25. Nagano Y, Milar BC, Goldsmith CE, et al. Development of selective media for the isolation of yeasts andf lamentous fungi from the sputum of adult patients with cysticf brosis (CF). J Cyst Fibros 2008; 7: 566-572.
26. Rainer J, Kaltseis J, de Hoog GS, Summerbell RC. Eff cacy of a selective isolation procedure for members of the Pseudallescheria boydii complex. Antonie Van Leeuwenhoek 2008; 93: 315-322.
27. Doern GV, Brogden-Torres B. Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cysticf brosis. J Clin Microbiol 1992; 30: 2740-2742.
28. Peltroche-Llacsahuanga H, Dohmen H, Haase G. Recovery of Candida dubliniensis from sputum of cysticf brosis patients. Mycoses 2002; 45: 15-18.
29. Kontoyiannis DP, Reddy BT, Torres HA, et al. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis 2002; 34: 400-403.
30. Wood GC, Mueller EW, Croce MA, Boucher BA, Fabian TC. Candida sp. isolated from bronchoalveolar lavage: clinical signif cance in critically ill trauma patients. Intensive Care Med 2006; 32: 599-603.
31. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-505.
32. Tavanti, A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 2005, 43: 284-292.
33. Balajee SA, Gribskov JL, Hanley E, et al. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005; 4: 625-632.
34. Balajee SA, Houbraken J, Verweij PE, et al. Aspergillus species identif cation in the clinical setting. Stud Mycol 2007, 59:39-46.
35. Gilgado F, Cano J, Gen é J, Sutton DA, Guarro J. Molecular and phe-notypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008, 46: 766-771.
36. Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identi-f cation of Aspergillus, Fusarium and the Mucorales in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009; 47: 877-884.